ARTELO BIOSCIENCES, INC. Accounts Payable and Other Accrued Liabilities, Current
ARTELO BIOSCIENCES, INC. (ARTL) had Accounts Payable and Other Accrued Liabilities, Current of $418.94 thousand as of 2021-05-31, per its 10-Q filed 2021-07-12.
Discontinued › Notes
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2021-07-12
- 2021-05-31: Accounts Payable and Other Accrued Liabilities, Current $418.94K.
- 2021-02-28: Accounts Payable and Other Accrued Liabilities, Current $583.97K.
- 2020-11-30: Accounts Payable and Other Accrued Liabilities, Current $474.06K.
- 2020-08-31: Accounts Payable and Other Accrued Liabilities, Current $490.22K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2021-05-31 | $418.94K 10-Q · filed 2021-07-12 |
| 2021-02-28 | $583.97K 10-Q · filed 2021-04-13 |
| 2020-11-30 | $474.06K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $490.22K 10-Q · filed 2021-07-12 |
| 2020-05-31 | $255.63K 10-Q · filed 2020-07-13 |
| 2020-02-29 | $431.91K 10-Q · filed 2020-04-13 |
| 2019-11-30 | $574.53K 10-Q · filed 2020-01-14 |
| 2019-08-31 | $348.86K 10-Q · filed 2020-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |